WKN DE: A14QXP / ISIN: FR0012127173

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV		Knock-Outs
Historisch			Analysen

Kurse + Charts + Realtime
Kurs + Chart
Chart (groß)
Times + Sales
Chartvergleich
Börsenplätze
Realtime Push
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Aktion
Portfolio
Watchlist

Orphan Synergy Europe - Pharma Times and Sales (STU)

Zeit	Kurs	Umsatz (Stk)
21:56:24	3,136
21:46:24	3,136
21:31:40	3,134
21:16:35	3,132
21:01:45	3,136
20:31:29	3,138
20:16:47	3,144
20:01:29	3,146
19:32:28	3,146
19:17:09	3,144
19:02:24	3,146
18:33:09	3,146
18:18:03	3,148
17:47:43	3,146
17:32:23	3,128
17:18:08	3,146
17:03:38	3,136
17:00:37	3,152	1 500
16:33:29	3,130
16:18:01	3,140
16:12:36	3,144	1 495
15:33:01	3,182
15:18:25	3,182
15:02:56	3,182
14:32:57	3,188
14:18:25	3,190
13:33:44	3,190
13:18:45	3,190
13:10:20	3,190
13:04:14	3,190
12:52:44	3,190
12:34:04	3,190
12:18:48	3,188
12:04:13	3,188
11:50:57	3,198

Kursrückgang	Kursanstieg	keine Kursänderung
(Balkenlänge beschreibt das Umsatzvolumen)

Analysen zu Orphan Synergy Europe - Pharma SA

Weitere Meldungen

22:17		Paramount agrees extensive delay in Warner Bros deal after states’ lawsuit
21:37		Warren Buffett Says Alphabet Is More Likely to Win Than 95% of Wall Street — But Adds ‘I Don’t Like It as Well as’ Coca-Cola And 4 Others
21:33		Investor Says His SpaceX Bet Has Cost him $200K So Far. 'We'll Learn How to Trade This Stock Eventually'
21:31		Paramount Agrees to Delay Warner Bros. Merger for Months
21:29		Advanced Micro Devices vs. Alphabet: What Do the Revenue Trajectories of These Artificial Intelligence Companies Tell Investors?
21:28		This Dirt Cheap Stock Reports Earnings July 30. Is It Finally Time to Buy Sirius XM?
21:27		Super Micro Just Reported $60 Billion of New Orders -- Here's Why Smart Investors Should Buy Dell Stock Now
21:24		Anthropic Unveils Claude Opus 5, Says New Model Beats Rivals on Coding and Business Tasks
21:15		Waymo explores split with Uber as robotaxi tensions deepen
21:11		Pinnacle Financial Founder Buys $1 Million Worth of Shares. What Does This Mean for Investors?
21:10		Forget Bitcoin, XRP: These 3 Altcoins Are Set Up for Big Moves Right Now
21:05		Nvidia, Meta and 23 Others Put Their Names on Open-Weight AI Letter — Google, Amazon and the Closed Labs Keep Theirs Off
21:05		Could $2,000 in Oklo Stock Today Set You Up for a Dream Retirement?
20:59		QUICK SPARK: RTX Is Prioritizing Broken Engines Over New Planes
20:58		Bitcoin, Ethereum, XRP, Dogecoin End Week Quietly as Analyst Predicts 'One Last Leg Lower'
20:57		Wall Street's New ETF Strategy? Copy, Paste, Repeat—and Hope for the Next DRAM
20:53		QUICK SPARK: Elon Musk Loses $80 Billion In A Single Week
20:52		AI Ships, American Steel: Saronic and Samsung Partner to Rebuild U.S. Maritime Power
20:51		Trump threatens EU with tariff probe over Google, tech fines
20:47		Intel Slides Despite Strong Quarter as Street Weighs $20 Billion Capex Plan
20:43		Should You Buy Royal Caribbean Stock Before July 28?
20:40		Stripe Eyes OpenRouter in Potential $10 Billion AI Infrastructure Deal
20:37		Why Intel, Micron and other major chip stocks are falling — even as the rest of tech holds up
20:33		QUICK SPARK: RTX Just Received Its First US Patriot Order in 30 Years
20:31		QUICK SPARK: Tesla Stock Heads For Worst Week Since March 2020
20:28		Nvidia CEO Jensen Huang Just Posted For the First Time on X. Here's What He Said.
20:27		ICC members vote to remove Chief Prosecutor Karim Khan amid sexual misconduct allegations
20:25		Why Is Nebius Stock Falling on Friday?
20:24		Why Lockheed Martin Stock Keeps Going Up
20:23		Billionaire Investor Dumps Thermo Fisher, Cuts Danaher As He Pares Life Sciences Tools Bets
20:22		Tenet's Blockbuster Quarter Sends Stock Flying, 2026 Outlook Gets Major Upgrade
20:21		Trump threatens new EU tariffs in retaliation for fines on US tech groups
20:21		Trump threatens new EU tariffs in retaliation for fines on US tech groups
20:15		Which Aerospace ETF is the Better Buy in 2026: Invesco Aerospace & Defense or U.S. Global Jets?
20:10		Sanofi Drops Dupixent Successor Candidate After Assessing Data
20:07		Trump Administration Admits Canceling Grants to States That Did Not Vote for Him
20:03		Curis Gains As Blood Cancer Drug Progresses, December Readout in Focus
20:03		Why Did Intel Stock Drop Friday?
20:03		Samsung Eyes First-Mover Edge, Adds Stablecoins to Wallet: 'Expand Beyond Cash and Savings'
20:01		Gentex Warns China Sales Will Keep Falling Through 2027
19:49		Don't Save for Retirement if You Haven't First Done This
19:45		Ondas Backs AI Counter-Drone Startup FPF Defense
19:40		Small Businesses Sue Trump Administration Over Latest Tariffs
19:33		Alphabet Just Proved Why It's a Top Artificial Intelligence (AI) Stock Once Again
19:30		Anthropic Releases Claude Opus 5 to Be Your New ‘Everyday’ Assistant
19:23		Why Badger Meter Stock Is Plummeting 18% Lower This Week
19:23		French Fry Giant Lamb Weston Fries Wall Street Estimates, Serves up Strong 2027
19:17		SpaceX is banking on a successful Starship launch to stem the stock’s bleeding
19:05		Don’t rush to save Social Security, AARP tells Congress: ‘It should be debated openly — not through an accelerated process’
19:02		Sias questions Accrelist after audit adjustments quadruple its FY2026 net loss

1 | Weiter

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Weitere Aktien: Tixfi PTC Industries Nippon Ski Resort Development AmTrust Financial Services Breathe eCig

Kontakt - Impressum - Werbung - Barrierefreiheit

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2026 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 80% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	24.07.2026 22:44
Kaufwert:	EUR
	Hinzufügen Speichern

Orphan Synergy Europe - Pharma Aktie

WKN DE: A14QXP / ISIN: FR0012127173

Orphan Synergy Europe - Pharma Times and Sales (STU)

Analysen zu Orphan Synergy Europe - Pharma SA

Weitere Meldungen